EUVIMEDEUVIMED entdecken
Crossref

Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2024

Monica M Lahra, Tiffany R Hogan

Communicable Diseases Intelligence · 2025

DOI: 10.33321/cdi.2025.49.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Communicable Diseases Intelligence, 2025. Verfasst von Monica M Lahra und 1 weiteren Autor:innen. Beteiligte Einrichtung: The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of …. Hauptthemen laut MEDLINE: Meningococcal Infections, Neisseria meningitidis, Population Surveillance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and molecular based techniques. Data contained in quarterly reports are restricted to a description of case numbers of IMD by jurisdiction and serogroup, where known, and expanded in 2024 to include antimicrobial resistance data for ceftriaxone, penicillin, ciprofloxacin and rifampicin. A full analysis of laboratory confirmations of IMD in each calendar year are contained in the AMSP annual reports.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningococcal InfectionsNeisseria meningitidisPopulation SurveillanceHumansAustraliaAnti-Bacterial AgentsSerogroupCiprofloxacinCeftriaxoneDrug Resistance, BacterialDisease NotificationMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Neisseria meningitidisantimicrobial resistancedisease surveillanceinvasive meningococcal disease

Substanzen

Anti-Bacterial AgentsCiprofloxacinCeftriaxone

Autor:innen und Institutionen

  • The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia.
  • The School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW, 2052, Australia.

Zitieren

APA

Lahra, M. M., & Hogan, T. R. (2025). Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2024. Communicable Diseases Intelligence. https://doi.org/10.33321/cdi.2025.49.017

Vancouver

Lahra MM, Hogan TR. Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2024. Communicable Diseases Intelligence. 2025. doi:10.33321/cdi.2025.49.017

BibTeX
@article{Lahra2025,
  author = {Lahra, Monica M and Hogan, Tiffany R},
  title = {Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2024},
  journal = {Communicable Diseases Intelligence},
  year = {2025},
  doi = {10.33321/cdi.2025.49.017}
}
Kostenlos starten →